StonvexLoading…
StonvexStonvexStonvexCore line items from INDI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $217.39M | $216.68M | $223.17M | $110.80M |
Operating Income | $-154.22M | $-170.08M | $-135.42M | $-119.13M |
Net Income | $-143.07M | $-132.60M | $-117.63M | $-43.40M |
EPS (Diluted) | $-0.73 | $-0.76 | $-0.81 | $-0.37 |
Total Assets | $840.79M | $941.39M | $818.88M | $603.35M |
Total Liabilities | $456.77M | $495.99M | $341.85M | $289.02M |
Cash & Equivalents | $145.46M | $274.25M | $151.68M | $321.63M |
Free Cash Flow OCF − CapEx | $-71.42M | $-72.94M | $-117.14M | $-84.31M |
Shares Outstanding | 197.25M | 175.03M | 145.19M | 118.66M |